Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20220526054990N1
IRCT20220526054990N1
Completed
Phase 3

Evaluation of the effect of fluvoxamine in preventing neuropsychiatric symptoms of Long COVID syndrome

Artesh University of Medical Sciences0 sites96 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsong or Post COVID syndrome.Post COVID-19 condition occurs in individuals with a history of probable or confirmed SARS CoV-2 infection, usually 3 months from the onset of COVID-19 with symptoms and that last for at least 2 months and cannot be explained by an alternative diagnosis.U09.9

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
ong or Post COVID syndrome.
Sponsor
Artesh University of Medical Sciences
Enrollment
96
Status
Completed
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Artesh University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • •Confirmed COVID infection by infectious disease specialist
  • •Age over 15 years

Exclusion Criteria

  • •History of epilepsy
  • •History of mania
  • •History of depression
  • •Use of other antidepressants
  • •Pregnancy and lactationK
  • •Kidney dysfunction
  • •Liver dysfunction
  • •History of cardiac arrhythmia
  • •Any drug allergy to fluvoxamine, including skin allergies
  • •Severe side effects of fluvoxamine, including malignant neuroleptic syndrome

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 4
A longitudinal study of the fluvoxamine treatment for the structural and functional connectivity between the orbitofrontal cortex and the ventral striatum in obsessive compulsive disorder
JPRN-jRCT1051180029akamae takashi30
Recruiting
Not Applicable
A longitudinal study of the fluvoxamine treatment for the structural and functional connectivity between the orbitofrontal cortex and the ventral striatum in obsessive compulsive disorderobsessive-compulsive disorder
JPRN-UMIN000022815Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine,30
Not yet recruiting
Phase 4
To assess the effectiveness and safety of adding L-methyltetrahydrofolate in addition to fluvoxamine in patients with Obsessive compulsive DisorderHealth Condition 1: F42- Obsessive-compulsive disorder
CTRI/2024/05/067542PT B.D Sharma UHS Rohtak
Active, not recruiting
Not Applicable
The effect of fluvoxamine and ciprofloxacin on the pharmacokinetics and pharmacodynamics of nabumetone: A three-phase double-blind placebo-controlled cross-over study.Pharmacokinetics and pharmacodynamics, healthy volunteer trial
EUCTR2008-007647-14-FITurku University Hospital12
Not yet recruiting
Not Applicable
Comparison of drugs, Fluvoxamine ans Sertraline in patients with OCD in terms of efficacy and effect on neuro-psychological functions.Health Condition 1: F42- Obsessive-compulsive disorder
CTRI/2020/01/022890Government Medical College and Hospital Chandigarh